SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (940)6/13/2002 1:05:07 PM
From: scaram(o)uche  Respond to of 1834
 
Cool thought.

I like the diversity of projects at NBIX. You did say "near term driver", so I don't have an opinion beyond "cool thought".



To: tuck who wrote (940)6/13/2002 11:39:00 PM
From: Miljenko Zuanic  Respond to of 1834
 
DOVP, with two candidates in clinic is interesting play, even without royalty from NBIX.

3.5% does not sound bad for doing NOTHING.

In time I will need to do DD on their candidates. Maybe idea as an arbitrage isn't bad, but I do think that NBIX itself is even better idea.

Miljenko


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News